Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
11/22/2000 | EP1054063A2 Process for the production of naturally folded and secreted proteins |
11/22/2000 | EP1053355A2 Pna and dna conjugates and methods for preparation thereof |
11/22/2000 | EP1053325A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
11/22/2000 | EP1053304A2 Crystalline tnf-alpha-converting enzyme and uses thereof |
11/22/2000 | EP1053249A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production |
11/22/2000 | EP1053241A1 Novel dimerizing agents, their production and use |
11/22/2000 | EP1053021A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media |
11/22/2000 | EP0827502B1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels |
11/22/2000 | CN1274362A Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline |
11/21/2000 | US6150507 Method for producing a purified hemoglobin product |
11/21/2000 | US6150503 Phosphorylated fusion proteins |
11/21/2000 | US6150179 Measuring internuclear dipole-dipole interaction strengths between selected nuclei in sample of binder compound using nuclear magnetic resonance; accurate drug design and drug screening |
11/21/2000 | US6150147 Laying out a pattern of nucleotide sequences on surface of a substrate; forming layout of nucleic acid sequences on the surface of a substrate and reducing electrostatic charge during process |
11/21/2000 | US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections |
11/21/2000 | CA2020477C Sustained release formulations of water soluble peptides |
11/16/2000 | WO2000068690A1 Method for detecting proteins under mutual interaction |
11/16/2000 | WO2000068398A1 Purification method by affinity |
11/16/2000 | WO2000068260A1 Methods for protein purification using aqueous two-phase extraction |
11/16/2000 | WO2000068257A1 C-linked neoglycopeptides, their combinatorial synthesis and use |
11/16/2000 | WO2000068252A1 Methods and compositions for controlled polypeptide synthesis |
11/16/2000 | WO2000067901A1 Affinity-controlling material with the use of stimulus-responsive polymer and separation/purification method with the use of the material |
11/16/2000 | WO2000067894A2 Methods of software driven flow sorting for reiterative synthesis cycles |
11/16/2000 | WO2000034784A9 Protein scaffolds for antibody mimics and other binding proteins |
11/16/2000 | WO2000032814A3 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof |
11/16/2000 | WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
11/16/2000 | WO2000014113A3 Method of stimulating prosaposin receptor activity |
11/16/2000 | DE19919149A1 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Of interferon alpha-2 derived peptide homodimers and peptide heterodimers |
11/16/2000 | DE19919148A1 Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Interleukin 12 derived peptide homodimers and peptide heterodimers |
11/16/2000 | CA2372526A1 Methods and compositions for controlled polypeptide synthesis |
11/16/2000 | CA2372513A1 Methods for protein purification using aqueous two-phase extraction |
11/15/2000 | EP1051483A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof |
11/15/2000 | EP1051432A2 Method for reducing immunogenicity of proteins |
11/15/2000 | EP1051430A2 Array fabrication methods |
11/15/2000 | EP1051245A1 Method of quality control in manufacturing processes |
11/15/2000 | EP0771359A4 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
11/15/2000 | EP0714402B1 Polymer modification |
11/15/2000 | EP0658168B1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
11/15/2000 | CN1273599A Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCs,use thereof for cloning and chimerization |
11/14/2000 | US6147212 Proline-naphthylalanine dipeptide amidated with an acyl derivative on the n-terminus and a 4-phenyl-1-piperazinyl derivative on the carboxyl terminus; neurokinin (tachykinin) antagonist |
11/14/2000 | US6147205 Arylalkyloxycarbonyl groups; for solid phase synthesis of oligonucleotides and polypeptides |
11/14/2000 | US6147189 Biosynthesis of structurally confined protein; synthesize a protein with a tripeptide active position composed of arginine, glycine, asparagine and proline residues at terminals . |
11/14/2000 | US6146635 System for the expression of heterologous antigens as fusion proteins |
11/09/2000 | WO2000066761A2 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
11/09/2000 | WO2000066629A1 Modified exendins and exendin agonists |
11/09/2000 | WO2000066253A1 Method for separating organic substances from an aqueous mixture |
11/09/2000 | WO2000029617A3 Water-soluble luminescent quantum dots and bioconjugates thereof |
11/09/2000 | CA2372214A1 Modified exendins and exendin agonists |
11/09/2000 | CA2371770A1 Process for the separation of organic substances from an aqueous mixture |
11/09/2000 | CA2370113A1 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
11/08/2000 | EP1049792A1 Methods for recovering polypeptides from plants and portions thereof |
11/08/2000 | EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
11/08/2000 | EP1049716A1 Purification of fibrinogen |
11/08/2000 | EP1049481A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
11/08/2000 | CN1272550A Preparation method of natural folding and secreted protein |
11/08/2000 | CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity |
11/08/2000 | CN1058260C Na-2-(4-nitrophenulsulfonyl) ethoxycarbonyl-amino acid |
11/07/2000 | US6143932 Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein |
11/07/2000 | US6143739 Antimicrobial agents mainly active against gram positive bacteria |
11/07/2000 | US6143716 Liposomal peptide-lipid conjugates and delivery using same |
11/07/2000 | US6143497 Synthesizing random oligomers on particles using identification tags to facilitate identification of sequence of monomers |
11/07/2000 | US6143297 Immunizing a mammals; forming antibodies |
11/07/2000 | CA2075711C Vaccine and method therefor |
11/07/2000 | CA2024767C Interferon-gamma receptor fragment and its production |
11/02/2000 | WO2000065521A2 System and method for polymer notation |
11/02/2000 | WO2000065467A1 Methods for identifying pharmacophore containing molecules from a virtual library |
11/02/2000 | WO2000065099A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof |
11/02/2000 | WO2000064938A2 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
11/02/2000 | WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
11/02/2000 | WO2000064843A1 Functionalised solid support for alpha-oxoaldehyde synthesis |
11/02/2000 | WO2000064579A1 Use of a composite polymer-coated sorbent for separation, purification, desalting and concentration of biopolymers |
11/02/2000 | WO2000064483A2 Releasable linkage and compositions containing same |
11/02/2000 | EP1048732A1 Process for producing natural folded and secreted proteins |
11/02/2000 | EP1048674A1 Method for separating and purifying aspartame and aspartame derivative |
11/02/2000 | EP1047771A2 Method of refolding angiostatin |
11/02/2000 | EP1047445A1 Modified enzymes and their use for peptide synthesis |
11/02/2000 | CA2643162A1 Polymer identification, compositional analysis and sequencing, based on property comparison |
11/02/2000 | CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2 |
11/02/2000 | CA2370298A1 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
11/02/2000 | CA2368793A1 Releasable linkage and compositions containing same |
11/02/2000 | CA2368197A1 Methods for identifying pharmacophore containing molecules from a virtual library |
11/02/2000 | CA2367594A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof |
11/01/2000 | CN1058021C New peptides derived from trifluorumethylketones, process for their preparation and pharmaceutical compositions which contain them |
10/31/2000 | US6140493 Method of synthesizing diverse collections of oligomers |
10/31/2000 | US6140475 Controlled dissolution crosslinked protein crystals |
10/31/2000 | US6140469 Protein isolate having an increased level of isoflavone compounds and process for producing the same |
10/31/2000 | US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre) |
10/31/2000 | US6140133 Device and process for synthesizing macromolecules |
10/31/2000 | US6139746 Method employing one or more cross-flow filter elements and one or more types of chromatography resins, in combination, to provide purification with advantageous yield, product purity, and cost- and time-efficiency |
10/31/2000 | CA1341131C Human nerve growth factor |
10/26/2000 | WO2000063683A1 Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database |
10/26/2000 | WO2000063419A1 Combinatorial chemical library supports having indicia at coding positions and methods of use |
10/26/2000 | WO2000063248A2 Highly purified gonadotropin compositions and process for preparing them |
10/26/2000 | WO2000063243A1 Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii |
10/26/2000 | WO2000034315A8 Purification of echinocandin cyclopeptide compounds |
10/26/2000 | WO2000020112A3 Chemical constructs and their uses |
10/26/2000 | WO2000013018B1 Support for a method for determining analytes and a method for producing the support |
10/26/2000 | WO2000011032A9 Method for producing biostatin (tt-232 triacetate) and analogs thereof |
10/26/2000 | DE19960346A1 Applying materials to a support, useful for combinatorial synthesis of peptides, e.g. for diagnosis, by incorporating materials in meltable particles and delivery through a printer |
10/26/2000 | CA2758956A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
10/26/2000 | CA2370749A1 Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database |